Macbee Planet (7095) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
11 Jun, 2026Executive summary
Revenue and profit declined year-over-year for the first time since foundation, mainly due to specific circumstances with major existing clients, despite an increase in new clients with significant monthly sales.
The LTV Marketing segment saw revenue fall 2.7% and segment profit decrease 13.9% due to major client factors.
Service expansion included the acquisition of MOJA (SNS consulting), launch of vertical media in wellness, and adoption of IFRS.
Total assets increased by 1,023 million yen to 24,091 million yen, driven by higher receivables, goodwill, and financial assets.
Cash and cash equivalents at year-end were 7,311 million yen, down 195 million yen from the previous year.
Financial highlights
FY04/2026 revenue: ¥50,579 million, down 2.1% year-over-year; operating profit: ¥3,650 million, down 29.4% year-over-year.
Operating profit margin decreased from 10.0% to 7.2%.
Gross profit fell to ¥8,642 million, a 6.4% year-over-year decrease; SG&A expenses rose to ¥4,991 million.
Net profit attributable to owners: ¥2,353 million, down 31.6% year-over-year.
EPS: ¥169.49; dividend per share increased to ¥55.
Outlook and guidance
FY04/2027 forecast: revenue of ¥51,000 million (+0.8% YoY); operating profit of ¥3,000 million (-17.8% YoY); profit attributable to owners projected at ¥1,900 million (-19.3% YoY); EPS forecast at ¥152.53.
Dividend policy revised to maintain ¥55 per share, abandoning the 20% payout ratio.
Continued focus on acquiring new clients and expanding transaction volume with existing clients amid economic uncertainty.
Latest events from Macbee Planet
- Revenue and profit fell sharply year-over-year, but full-year guidance is maintained.7095
Q3 20267 Apr 2026 - Operating profit and margin fell as revenue growth slowed, leading to a downward forecast revision.7095
Q2 202611 Dec 2025 - Q1 revenue up 11% year-over-year, but profit fell sharply on higher ad costs; recovery forecast.7095
Q1 202611 Sep 2025 - Sales and profits more than doubled, with strong outlook and a 4-for-1 stock split ahead.7095
Q4 202424 Jul 2025 - Record sales and profit growth, led by medical and LTV Marketing, with a major share buyback.7095
Q1 202524 Jul 2025 - Sales up 30% in 1H, with strong growth in medical, finance, and LTV Marketing.7095
Q2 202524 Jul 2025 - Net sales and profits rose sharply, with upgraded guidance and strong LTV Marketing growth.7095
Q3 202524 Jul 2025 - Record sales and profit growth, with strong FY2026 outlook and expanded shareholder returns.7095
Q4 202524 Jul 2025